Latest Strategy News

Toro Energy has completed a re-optimisation of its Lake Maitland mining pit at the Wiluna Uranium Project, integrating updated uranium and vanadium resource estimates and rising cost assumptions. The company is progressing a scoping study update while engaging with native title groups, positioning itself amid strengthening uranium market conditions.

UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.

Turaco Gold has confirmed a new gold discovery at its Baffia prospect and is poised to release an updated Mineral Resource Estimate for its flagship Afema Project, signaling significant resource growth potential.

Kalamazoo Resources Limited reported a challenging quarter with ongoing negative cash flows but plans a $0.8 million capital raise to sustain its exploration activities.

Kore Potash has completed an Optimised Definitive Feasibility Study for its Kola Potash Project, outlining a $2.07 billion capital cost and a 23-year mine life. The company also secured $10.1 million in funding and holds $10.2 million in cash as it prepares for construction.

Kairos Minerals has kicked off its biggest-ever drilling program at the Mt York Gold Project, aiming to significantly expand its 1.4 million ounce gold resource while advancing key agreements with traditional owners and neighbouring Pilbara Minerals.

Blackstone Minerals has entered a binding agreement to merge with IDM International, acquiring the high-grade Mankayan copper-gold project in the Philippines. This strategic move positions Blackstone at the forefront of critical metals and precious metals markets amid growing global demand.

NSX Limited reported a net cash outflow from operations of AUD 1.3 million in Q3 2025 but is bolstering its liquidity through a new capital raising initiative to sustain ongoing activities.

Zuleika Gold Limited has progressed its exploration strategy with a comprehensive targeting review ahead of planned 2025 drilling, while also securing favorable court rulings in ongoing litigation related to the K2 Project.

Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.